OUR SUCCESSFUL STORY

NANOGEN BIOPHARMACEUTICAL is leading company that doing research and development of biopharmaceutical APIs, and specific therapeutic injections from recombinant DNA and protein technology in Asia Pacific region.

We are focus mainly on development of biopharmaceutical products from gene to therapy, serving high quality and innovative drug products for treatment of hepatitis B, hepatitis C, anemia due to chronic renal failure, myocardial infarction and cancer…

RECENT NEWS

Molecular and Cell Biology book award program 2014

For the first time, Nanogen Biopharmaceutical presented a Molecular and Cell Biology book award program to the representatives...

Nguồn lực kiều bào - Kỳ 2: Thuốc đặc trị cho người Việt

công trong sản xuất thuốc đặc trị tại VN, doanh nhân Việt kiều Mỹ, TS Hồ Nhân được...

OUR LATEST PRODUCTS

LOTUSAN

Rituximab

Liquid vial

LOTUSAN (Rituximab) is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody...

FACEPTOR

Trastuzumab

Lyophilization vial

Trastuzumab is a recombinant DNA-derived humanized anti-HER2 monoclonal antibody which belongs to...

Hi-Tech Park considered good...

National Assembly Vice Chairwoman Nguyen Thi Kim Ngan said in her tour to the Hi-Tech Park in Ho...

CPhI Worldwide 2013 – Frankfurt,...

Well-known as an international interactive company in the biopharmaceutical market, Nanogen Biopharmaceutical...